About
Generics, Biologics, Small Molecules
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalGeneric Drug
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
0
As Collaborator
7
Total Enrollment
10,758
By Phase
PHASE4: 4NA: 2PHASE1: 1
By Status
COMPLETED: 4RECRUITING: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06767345Collaborator
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
PHASE4Recruiting
408 participants
Started: May 12, 2025 · Completed: Jun 25, 2028
NCT06649240Collaborator
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
NARecruiting
4,016 participants
Started: Oct 4, 2024 · Completed: Sep 30, 2030
NCT03611725Collaborator
Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI
NACompleted
352 participants
Started: Aug 15, 2018 · Completed: Dec 13, 2023
NCT03169985Collaborator
Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque
PHASE4Active, not recruiting
280 participants
Started: Jul 12, 2017 · Completed: Jan 28, 2027
NCT02044250Collaborator
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
PHASE4Completed
5,530 participants
Started: Feb 28, 2014 · Completed: Mar 31, 2021
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...